Investor Alert: Rosen Law Firm Announces Securities Class Action Deadline for Indivior PLC (INDV) Shareholders

Investors who purchased shares of Indivior PLC INDV are being alerted to the approaching deadline of October 1, 2024, for the role of lead plaintiff in a securities class action. The period in question spans from February 22, 2024, to July 8, 2024. Rosen Law Firm, recognized for its global advocacy on behalf of investors, emphasizes the importance of this deadline. Indivior PLC is known for specializing in buprenorphine-based prescription drugs that address opioid dependence as well as other co-occurring disorders, with its headquarters established in North Chesterfield, Virginia.

Understanding the Case

The lawsuit alleges that Indivior PLC made false and/or misleading statements and/or failed to disclose material adverse facts about the company's business, operations, and prospects. As a result, Indivior PLC's securities traded at artificially inflated prices during the class period. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Investors Should Do

Investors who have purchased shares of Indivior PLC INDV within the class period are encouraged to contact Rosen Law Firm to secure legal counsel before the October 1 deadline. Acting as a lead plaintiff is not a requirement to share in any potential class action recovery and is meant for investors interested in serving in the capacity of a representative party. For more information on the class action and what steps to take next, investors are suggested to seek legal advice promptly.

Indivior, Investment, Deadline